Literature DB >> 14592529

The pathogenesis of coeliac disease.

David Dewar1, Stephen P Pereira, Paul J Ciclitira.   

Abstract

Coeliac disease is a chronic enteropathy caused by intolerance to gluten proteins. The true prevalence of this condition is greater than previously thought, with increasing numbers of 'silent' cases being diagnosed. Untreated coeliac disease is associated with significant morbidity and increased mortality. There have been a number of advances in our understanding of the pathogenesis of coeliac disease, in particular the mechanisms whereby gluten epitopes are processed, become modified by tissue transglutaminase (tTG) and then interact with HLA restricted T cells. An improved understanding of the immune response to gluten is likely to lead to the development of novel strategies for the treatment of coeliac disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14592529     DOI: 10.1016/s1357-2725(03)00239-5

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  22 in total

Review 1.  Targeted modification of wheat grain protein to reduce the content of celiac causing epitopes.

Authors:  C Osorio; N Wen; R Gemini; R Zemetra; D von Wettstein; S Rustgi
Journal:  Funct Integr Genomics       Date:  2012-06-26       Impact factor: 3.410

2.  Effects of tissue transglutaminase on beta -amyloid1-42-induced apoptosis.

Authors:  Joseph J Wakshlag; Marc A Antonyak; Jason E Boehm; Karen Boehm; Richard A Cerione
Journal:  Protein J       Date:  2006-01       Impact factor: 2.371

Review 3.  New aspects in celiac disease.

Authors:  M I Torres; M A López Casado; A Ríos
Journal:  World J Gastroenterol       Date:  2007-02-28       Impact factor: 5.742

Review 4.  Diagnostic challenges in celiac disease and the role of the tissue transglutaminase-neo-epitope.

Authors:  Torsten Matthias; Sascha Pfeiffer; Carlo Selmi; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

5.  Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3.

Authors:  Karen M Lammers; Ruliang Lu; Julie Brownley; Bao Lu; Craig Gerard; Karen Thomas; Prasad Rallabhandi; Terez Shea-Donohue; Amir Tamiz; Sefik Alkan; Sarah Netzel-Arnett; Toni Antalis; Stefanie N Vogel; Alessio Fasano
Journal:  Gastroenterology       Date:  2008-03-21       Impact factor: 22.682

Review 6.  Novel trends in celiac disease.

Authors:  Torsten Matthias; Sandra Neidhöfer; Sascha Pfeiffer; Kai Prager; Sandra Reuter; M Eric Gershwin
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

7.  Prevalence of resistant occipital lobe epilepsy associated with celiac disease in children.

Authors:  Alper I Dai; Aylin Akcali; Celal Varan; Abdullah T Demiryürek
Journal:  Childs Nerv Syst       Date:  2014-02-25       Impact factor: 1.475

8.  Damaging effects of gliadin on three-dimensional cell culture model.

Authors:  Ersilia Dolfini; Luca Elli; Leda Roncoroni; Barbara Costa; Maria-Pia Colleoni; Vito Lorusso; Simona Ramponi; Paola Braidotti; Stefano Ferrero; Maria-Letizia Falini; Maria-Teresa Bardella
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

Review 9.  Coeliac disease: an update for pathologists.

Authors:  B C Dickson; C J Streutker; R Chetty
Journal:  J Clin Pathol       Date:  2006-10       Impact factor: 3.411

10.  Affinity maturation of immunoglobulin A anti-tissue transglutaminase autoantibodies during development of coeliac disease.

Authors:  A Westerlund; M Ankelo; S Simell; J Ilonen; M Knip; O Simell; A E Hinkkanen
Journal:  Clin Exp Immunol       Date:  2007-02-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.